Exploring and Comparing the Psychosocial Impacts of Vitiligo on a Broader Scale: An International Survey via the Use of Social Media Authors: Megan Noda, Mathew Ghodsian, Jonathan Chan Published: 2026 ABSTRACT ABSTRACTBackground/ObjectivesVitiligo is associated with substantial psychosocial burden; however, community‐based patient‐reported data remain limited, and existing instruments may not fully reflect patients' lived experience. This study explored the psychosocial impacts of vitiligo using social media‐based recruitment.MethodsAdults (≥ 18 years) with physician‐confirmed or self‐reported vitiligo were recruited via Facebook support groups between December 2023 and February 2024 to complete an anonymous online survey. Quantitative data included demographics and the 15‐item VitiQoL questionnaire. Qualitative responses addressing challenges, management, and barriers to care were analysed inductively, with emergent themes integrated with quantitative findings. Descriptive statistics and exploratory independent‐samples t‐tests were performed.ResultsA total of 181 participants responded, predominantly female (81.8%), and mainly from the UK (53.59%) and Australia (29.83%). Qualitative analysis identified stigmatisation and sun exposure as prominent challenges. Head and neck involvement was associated with poorer QoL, including altered grooming behaviours (3.78, SD 2.12, p < 0.001), clothing adaptations (4.42, SD 1.96, p < 0.001), difficulties forming new friendships (2.21, SD 2.01, p < 0.001), and limitations in daily activities (2.93, SD 2.15, p < 0.001). Males reported greater emotional impact (M = 4.27, SD 1.91, p = 0.014) and more difficulty forming friendships (M = 2.85, SD 2.09, p = 0.004) than female participants.ConclusionVitiligo is associated with significant psychosocial challenges, particularly stigma‐related distress, behavioural adaptations, and participation restrictions. These findings highlight the importance of addressing psychosocial wellbeing in clinical care, and the need for comprehensive QoL measures that better capture psychosocial and participation‐related impacts.Keywords: psychosocial burden, quality of life, social media, vitiligo, VitiQoL Introduction Vitiligo, an autoimmune disorder characterised by melanocyte depletion, presents as well‐demarcated depigmented macules [1]. It is the most prevalent depigmenting dermatological condition globally, affecting approximately 0.5%–2% of the population [2]. Although predominantly asymptomatic, the visible nature of vitiligo is associated with stigma and profound psychosocial burden, adversely affecting quality of life (QoL) [3, 4]. Existing research has largely focused on patients attending tertiary dermatology clinics, potentially under‐representing individuals managed in the community or disengaged from specialist care. To address this gap, we investigated the psychosocial impact of vitiligo in an international community‐recruited online cohort, exploring quality of life, barriers to dermatological consultation, and coping strategies using social media‐based recruitment to capture patient‐reported experiences beyond traditional clinical settings. In addition to QoL data, this study examined patient‐identified priorities, barriers to care, and behavioural adaptations using a mixed‐methods, community‐recruited cohort. Methods Participants were recruited through vitiligo‐specific Facebook support groups between December 2023 and February 2024 using a convenience sampling approach. This recruitment strategy was chosen to capture patient‐reported experiences beyond tertiary clinic populations; however, as participation was voluntary and restricted to social media users, the sample was not intended to be representative of the wider vitiligo population. Eligible respondents were ≥ 18 years, with physician‐confirmed or self‐reported vitiligo. Participants completed an anonymous online survey hosted on Qualtrics. Quantitative data included demographics and QoL assessment using the Vitiligo Quality of Life (VitiQoL) questionnaire, a validated 15‐item instrument employing a seven‐point Likert scale (Appendix S1). VitiQoL has demonstrated moderate correlation with self‐reported disease severity (r = 0.51, p < 0.0001) and strong convergence with Skindex‐16 (r = 0.816) and the Dermatology Life Quality Index (r = 0.832, p < 0.01) [4]. Due to a technical issue, one VitiQoL item contained incomplete data and was excluded from analysis. Qualitative data were elicited through three open‐ended questions exploring (i) challenges of living with vitiligo, (ii) strategies to improve disease management, and (iii) barriers to accessing dermatological care. A fourth item invited respondents to identify aspects of clinical management they considered important using multiple‐choice and free‐text responses. Survey items were developed based on literature review and consultation with a dermatology department in Perth, Western Australia. Qualitative data were analysed inductively using thematic analysis. Emergent themes, including stigmatisation, participation limitations, and behavioural adaptations, were identified and integrated with quantitative findings. Themes were iteratively refined through repeated review. Quantitative data were summarised using descriptive statistics. Exploratory independent‐samples t‐tests were performed using jamovi (v2.3) [5] to compare VitiQoL item scores across demographic and disease‐related subgroups. Given the exploratory nature of analyses, no adjustment was made for multiple comparisons. Results Demographics A total of 181 participants were included in the analysis, predominantly female (81.77%). Most participants were married (54.14%) or partnered (14.92%), and over half were employed full time (51.38%). Fitzpatrick skin phototype was most commonly type III (37.71%) and type IV (30.86%). Vitiligo most frequently involved the face and hands (each 81.14%), followed by the legs (75.43%) and arms (74.29%). Participants were primarily based in the United Kingdom (53.59%) and Australia (29.83%). Diagnostic assessments were primarily conducted by dermatologists (48.62%) or general practitioners (38.67%) (Table 1). TABLE 1Patient demographics. N % Gender Male3318.23Female14881.77 Age 18–24 years42.2125–34 years2011.0535–44 years4625.4145–54 years5530.3955–64 years4424.3165+ years126.63 Employment status Full‐time9351.38Part‐time4725.97Unemployed21.10Homemaker116.08Student42.21Retired2111.60Other31.66 Marital status Married9854.14Living with a partner2714.92Widowed42.21Divorced/separated2714.92Never been married2513.81 Who diagnosed vitiligo? Self‐diagnosis2312.71General practitioner7038.67Dermatologist8848.62 Family member affected Yes4425.14No12470.86Unsure74.00 Seen a dermatologist Yes13275.86No4224.14 Fitzpatrick skin type Type I63.43Type II2614.86Type III6637.71Type IV5430.86Type V2011.43Type VI31.71 Body part affected Face14281.14Head/neck11163.43Hands14281.14Arms13074.29Trunk11062.86Legs13275.43Genitals12470.86 Country Angola21.10Australia5429.83Belgium10.55Bhutan10.55India21.10Israel10.55Italy21.10Malaysia10.55Mauritius21.10Nigeria21.10Philippines10.55South Africa10.55Sweden31.66United Kingdom9753.59USA84.42Venezuela31.66 Patient demographics. Qualitative Analysis Challenges of Living With Vitiligo Stigmatisation (26.78%) and sun exposure (24.04%) were the most frequently reported challenges. Concerns regarding physical appearance (19.67%), self‐consciousness/embarrassment (16.94%) were also commonly expressed, alongside anxiety related to disease progression (12.57%) and concealment strategies (11.48%) (Table 2). TABLE 2Qualitative analysis.Thematic qualitative analysis: challenges of living with vitiligo N %Stigma4926.78%Sun exposure4424.04%Physical appearance3619.67%Self‐consciousness/embarrassment3116.94%Progression of disease2312.57%Camouflaging/covering up2111.48%Psychological health126.56%Physical symptoms84.37%Sexual relationships84.37%Socialising84.37%No cure or treatment84.37%No known underlying cause and autoimmune concerns52.73%Accessibility of treatment (cost and location)31.64%Feelings of isolation21.09%Time for treatment10.55%Thematic qualitative analysis: management priorities N %Development of effective treatments and cure4725.68%Nothing can be done2010.93%Camouflage/covering up techniques1910.38%Psychological management179.29%Unsure137.10%Public education105.46%Guidance on management105.46%Improved health professional knowledge84.37%Affordability/access to treatment73.83%Personal acceptance73.83%Education on skin care63.28%Nutrition & diet education63.28%Provision of compassionate care52.73%Updates of available treatment42.19%Improvements in sunscreen31.64%Autoimmune screening10.55%Support groups10.55%Thematic qualitative analysis: Important for doctors to address N %Multichoice: Reducing progression of vitiligo12573.10%Multichoice: Explaining the risks and benefits of different treatment11969.59%Multichoice: Education about vitiligo11969.59%Multichoice: Education on sun protection care9857.31%Multichoice: Managing anxiety8851.46%Multichoice: Improving colour of skin8046.78%Multichoice: Education on diet and supplements7845.61%Multichoice: Managing stress7543.86%Multichoice: Managing depression7242.11%Multichoice: Education on covering lesions5733.33%Multichoice: Managing physical symptoms (itch, pain)5029.24%Free text: Managing psychological health425%Free text: Managing potential autoimmune co‐morbidities425%Free text: Compassion318.75%Free text: Setting realistic expectations212.5%Free text: Referral to support groups212.5%Free text: Provision of vitiligo care212.5% Qualitative analysis. Management Priorities Approximately one‐quarter of participants prioritised access to effective treatments or a cure (25.68%), followed by guidance on camouflage techniques (10.38%) and psychological support (9.29%). A minority expressed scepticism regarding treatment efficacy (10.93%) (Table 2). What Is Important for Your Doctor to Address? Reducing the progression (73.10%) and education regarding treatment risks and benefits (69.59%) were most frequently identified priorities, with anxiety management (51.46%) frequently cited (Table 2). Barriers to Specialist Care Among participants who had not consulted a dermatologist, the predominant barrier was the belief that no effective treatments were available (47.62%), with cost/access (16.67%) also cited (Table 3). TABLE 3Barriers to specialist care (42 respondents). N %No treatment/nothing they can offer2047.62%Don't want treatment819.05%Cost/accessibility to a dermatologist716.67%Have not been offered a referral49.52%Not sure49.52%In the process of organising37.14% Barriers to specialist care (42 respondents). Quantitative Analysis Stigma Scores Facial and head and neck involvement were associated with significantly higher stigma scores, particularly regarding perceived judgement by others and self‐consciousness. Older age and marriage appeared protective, with lower reported stigma (Table 4). TABLE 4Statistically significant stigma scores.QuestionMeanSD T‐score p Age 65+ yearsWhen you were talking to someone, have you worried about what they may be thinking of you?2.092.63−2.250.026Have you worried about progression or spread of disease to new areas of the body?2.272.65−3.7< 0.001 Skin phototype Fitzpatrick IWhen you were talking to someone, have you worried about what they may be thinking of you?1.672.25−2.140.034 Marital status MarriedHave you felt embarrassed or self‐conscious because of your skin?3.842.07−2.300.023 Body part affected FaceHave you been bothered by the appearance of your skin condition?3.802.172.130.035Have you felt frustrated about your skin condition?4.002.082.590.011When you were talking to someone, have you worried about what they may be thinking of you?3.742.053.250.001Have you felt embarrassed or self‐conscious because of your skin?4.351.922.360.019Head/neckHave you felt frustrated about your skin condition?4.072.032.280.024When you were talking to someone, have you worried about what they may be thinking of you?3.752.012.250.026Have you felt embarrassed or self‐conscious because of your skin?4.501.782.890.004 Seen a dermatologist YesHave you felt embarrassed or self‐conscious because of your skin?4.391.802.520.013 Statistically significant stigma scores. Participation Limitation Scores Male sex was associated with higher scores on selected participation items, particularly affecting emotional wellbeing (M = 4.27 ± SD 1.91 vs. F = 3.21 ± SD 2.01, p = 0.014) and forming new friendships (M = 2.85 ± SD 2.09 vs. F = 1.64 ± SD 1.88, p = 0.004). Similarly, visible disease involvement (face/head and neck) led to increased participation limitations. Older age and marriage were associated with fewer participation limitations (Table 5). TABLE 5Statistically significant participation limitation scores.QuestionMeanSD T‐score p Gender MaleHas your skin condition affected you emotional wellbeing?4.271.912.470.014Has your skin condition affected your chances of making new friends?2.852.092.930.004 Age 65+ yearsHas your skin condition made it hard to show affection?0.461.51−2.390.018Have you been afraid that people will find fault with you?0.821.40−2.250.003 Skin phototype Fitzpatrick IHas your skin condition affected your social or leisure activities?1.331.51−2.100.037Fitzpatrick IIIHas your skin condition made it hard to show affection?1.391.84−2.710.007Has your skin condition affected your daily activities?1.982.00−2.370.019Has your skin condition affected your social or leisure activities?2.612.12−2.490.014Has your skin condition affected your emotional wellbeing?2.981.92−1.990.049Has your skin condition affected your chances from making new friends?1.391.48−2.280.024Fitzpatrick VHas your skin condition affected your social or leisure activities?4.231.992.390.018 Employment status Unemployed or looking for workHas your skin condition affected your chances from making new friends?5.0002.330.021RetiredHave you been afraid that people will find fault with you?1.681.86−2.250.026 Marital status MarriedHas your skin condition made it hard to show affection?1.341.82−4.02< 0.001Has your skin condition affected your daily activities?2.082.16−2.540.012Have you been afraid that people will find fault with you?2.252.26−3.030.003Has your skin condition affected your social or leisure activities?2.762.13−2.350.020Has your skin condition affected your emotional wellbeing?2.991.97−2.620.010Has your skin condition affected your chances from making new friends?1.391.71−3.110.002Divorced or separatedHas your skin condition made it hard to show affection?3.002.472.570.011Has your skin condition affected your daily activities?3.482.122.520.013Has your skin condition affected your social or leisure activities?3.892.101.980.050Has your skin condition affected your chances from making new friends?2.932.153.260.001Never been marriedHave you been afraid that people will find fault with you?3.742.342.300.023 Body part affected FaceHave you been afraid that people will find fault with you?2.962.232.400.018Has your skin condition affected your chances from making new friends?2.081.993.260.001Head/neckHas your skin condition made it hard to show affection?2.272.282.070.040Has your skin condition affected your daily activities?2.932.153.41< 0.001Have you been afraid that people will find fault with you?3.042.222.200.029Has your skin condition affected your social or leisure activities?3.532.043.220.002Has your skin condition affected your emotional wellbeing?3.641.943.220.029Has your skin condition affected your chances from making new friends?2.212.013.40< 0.001ArmsHas your skin condition made it hard to show affection?1.792.23−2.270.022LegsHas your skin condition affected your social or leisure activities?3.402.122.630.009 Seen a dermatologist YesHas your skin condition made it hard to show affection?2.212.272.180.031Has your skin condition affected your daily activities?2.722.182.200.030Has your skin condition affected your social or leisure activities?3.372.082.480.014Has your skin condition affected your emotional wellbeing?3.601.882.470.015Has your skin condition affected your chances from making new friends?2.032.012.330.021 Statistically significant participation limitation scores. Behaviour Scores Behaviour adaptations were most strongly associated with disease distribution, particularly head and neck, trunk, and limb involvement. Participants with darker skin phototypes demonstrated poorer sun protection behaviours (Table 6). TABLE 6Statistically significant behaviour scores.QuestionMeanSD T‐score p Age 18–24 yearsHas your skin condition influenced the clothes you wear?1.001.73−2.130.03555–64 yearsHas your skin condition affected your sun protection efforts during recreation (i.e., limiting exposure time during peak sun hours, seeking shade, wearing hat, long sleeves, or pants)?5.221.492.650.009 Skin phototype Fitzpatrick VIHas your skin condition influenced the clothes you wear?0.330.58−2.660.009Has your skin condition affected your sun protection efforts during recreation (i.e., limiting exposure time during peak sun hours, seeking shade, wearing hat, long sleeves, or pants)?22.65−2.190.030 Body part affected Head/neckHas your skin condition influenced the clothes you wear?4.421.965.37< 0.001Has your skin condition affected your grooming practices (i.e., hairstyle, use of cosmetics)?3.782.123.45< 0.001Has your skin condition affected your sun protection efforts during recreation (i.e., limiting exposure time during peak sun hours, seeking shade, wearing hat, long sleeves, or pants)?4.831.752.790.006HandsHas your skin condition affected your grooming practices (i.e., hairstyle, use of cosmetics)?3.162.3−2.180.030ArmsHas your skin condition affected your sun protection efforts during recreation (i.e., limiting exposure time during peak sun hours, seeking shade, wearing hat, long sleeves, or pants)?4.761.82.920.004TrunkHas your skin condition influenced the clothes you wear?4.202.173.40< 0.001Has your skin condition affected your sun protection efforts during recreation (i.e., limiting exposure time during peak sun hours, seeking shade, wearing hat, long sleeves, or pants)?4.811.852.620.010LegsHas your skin condition influenced the clothes you wear?4.182.174.22< 0.001Has your skin condition affected your sun protection efforts during recreation (i.e., limiting exposure time during peak sun hours, seeking shade, wearing hat, long sleeves, or pants)?4.781.812.980.003 Seen a dermatologist YesHas your skin condition influenced the clothes you wear?3.982.262.170.032 Statistically significant behaviour scores. Discussion This mixed‐method study demonstrates the substantial psychosocial burden associated with vitiligo in an online community‐recruited cohort, extending insights beyond tertiary dermatology settings. Stigma, participation limitations, and behavioural adaptations emerged as central themes, reinforcing the multidimensional impact of vitiligo on QoL. Beyond confirming findings from clinic‐based studies, this work highlights four under‐recognised dimensions: high reporting of sensitive site involvement in the anonymous online setting, treatment‐related nihilism as a barrier to care, gender‐specific psychosocial differences, and substantial behavioural adaptations related to visible disease distribution. Demographics The characteristics of this cohort suggest that it should not be interpreted as representative of the global vitiligo population, but rather as a self‐selected, community‐engaged subgroup recruited through social media support networks. Compared with the VitiQoL pilot study by Lilly et al. our cohort was similar in age distribution, marital status and skin phototype, but showed a marked female predominance (81.8% vs. 53.3%) [4]. This likely reflects differential participation in online support communities, where women have been shown to engage more actively in health‐related group communication [6]. The sample was also geographically concentrated, with most respondents residing in the United Kingdom and Australia, which may limit applicability to populations from other cultural and health‐system contexts. Notably, our cohort demonstrated substantially higher rates of visible site involvement compared with previously published studies. Facial and hand involvement were each reported by over 80% of participants, compared with lower rates reported by Bibeau et al. (head 26.5%, hands 35.6%) [7]. Genital involvement in our cohort (70.9%) was also markedly higher than reported by Bibeau et al. (27%–44%) [7] and Ongenae et al. (46%) [8]. These differences likely reflect recruitment methodology. Individuals with more extensive, visible, or personally burdensome disease may be more motivated to engage with support groups and participate in surveys examining psychosocial impact. Additionally, while Bibeau et al. confirmed diagnoses through specialist review of photographs, our study—consistent with Ongenae et al. [8] and VALIANT [9]—relied on self‐report. The anonymity of online participation may have facilitated greater disclosure of involvement at sensitive sites [10], highlighting the importance of clinicians proactively inquiring about genital and other concealed areas. Differences between our findings and VALIANT may also relate to geographic variations. While Fitzpatrick skin types IV–VI were comparable (44% vs. VALIANT 40%), approximately 30% of our cohort was Australian compared with 2% in VALIANT [9], potentially enhancing relevance to an Australian population. Notably, VALIANT also included self‐reported body surface area, which was not captured in our study and may have provided a complementary measure of disease severity. Qualitative Analysis Challenges of Living With Vitiligo Psychosocial themes of stigma, physical appearance, self‐consciousness and embarrassment were prominent, collectively affecting approximately one quarter of participants. These findings align with Salama et al., demonstrating a substantial psychological burden among individuals with vitiligo [11]. Nearly half of participants identified stress and mental health management as important aspects for clinicians to address, highlighting the importance of routine assessment of psychological wellbeing and the incorporation of supportive care within clinical consultations. Management Priorities and Barriers to Specialist Care A quarter of participants prioritised the development of effective treatments or a cure, while one in ten perceived that no effective management options were available. In contrast, most respondents identified reducing disease progression and receiving clear education regarding treatment risks and benefits as key priorities. Among those who had not consulted a dermatologist, the predominant barrier was the perception that no treatment was available, with cost or access cited less frequently. These findings suggest a gap in patient and primary care awareness of available and emerging vitiligo therapies, highlighting the importance of improved education and referral pathways. Almost 60% of participants identified sun protection education as an important aspect of care. Although often overlooked in time‐limited consultations, sun protection counselling is essential to reduce the risk of sunburn, photoaging and skin cancer in depigmented skin, despite reports of lower skin cancer rates in vitiligo [12]. Participants with darker skin phototypes (Fitzpatrick VI) demonstrated poorer sun‐protective behaviours, suggesting underestimation of ultraviolet susceptibility in affected skin. Interest in dietary and supplement advice was common. While there is limited robust evidence on the use of diet and supplements in the treatment paradigm of vitiligo, unsurprisingly, the literature does support that patients with poorer diets, low in protein, vitamins B12, C, D and antioxidants [13] as well as patients with obesity and sedentary lifestyles have poorer outcomes with their vitiligo [14], possibly due to the immunomodulatory effect of vitamin D and the inflammatory associations of metabolic syndrome. Quantitative Analysis Stigma Participants reported considerable challenges related to stigmatisation, altered appearance, and heightened self‐consciousness, reflected in both qualitative responses and elevated VitiQoL stigma scores. These findings are consistent with prior research; a systematic review by Ezzedine et al. demonstrated the substantial psychosocial burden of visible lesions, particularly facial lesions [3]. The prominence of facial involvement underscores the societal emphasis on aesthetics, with visibility directly influencing social interactions and self‐confidence [15]. Older age and being married appeared protective, likely reflecting greater social support and adaptive coping mechanisms. Participation Limitations Sun exposure was a key contributor to participation limitations. Given that nearly one‐third of participants resided in Australia (29.83%) and that data collection occurred during summer months, environmental and seasonal factors may have amplified this burden. Consistent with our findings, Bhatia et al. reported individuals with vitiligo in France and the United States similarly restricted sun exposure due to their condition [16]. Facial and head and neck involvement was strongly associated with limitations in engaging in daily activities, emotional wellbeing and forming new social relationships. Contrary to expectations, hand involvement was not linked to such limitations in our cohort, despite previous literature emphasising the psychosocial impact of visible lesions [3]. Interestingly, males in our cohort reported greater impact on emotional wellbeing and forming new friendships, contrasting with previous literature reporting higher psychosocial burden among females [3, 17]. One possible explanation is that anonymous online participation may reduce barriers to disclosure among men [18], although this finding should be interpreted cautiously given the modest number of male respondents. If replicated, this may suggest that anonymous survey methodologies capture aspects of psychosocial burden that are less readily disclosed in traditional clinical or research settings. Marriage and older age were again associated with fewer participation limitations. These findings parallel those of Bibeau et al., who observed greatest limitations among individuals aged 25–44 years, with improvement at older ages [7]. Marriage likely confers protective social support [19], while the “response shift” phenomenon, whereby older adults adjust their perception of QoL, may partly explain improved social functioning [20]. Behavioural Changes Behavioural adaptations included clothing modification, camouflage use, altered grooming practices, and increased sun‐avoidant behaviours. Older participants placed greater emphasis on sun protection, while those with Fitzpatrick type VI reported stronger influences of vitiligo on clothing choices. By contrast, younger participants reported minimal impact on clothing selection. Given the association between sunburn, photoaging and lower rates (but still susceptible to) skin cancer and vitiligo [21], clinicians should promote sun‐safe practices across all age groups, but particularly the younger cohort for whom early intervention may be particularly important. Although prior studies have linked higher Fitzpatrick skin types with reduced QoL [2], our findings demonstrated only partial correlation, possibly reflecting the predominance of respondents from the UK and Australia where cultural attitudes towards vitiligo differ from those reported in Nigeria [22] and parts of Asia [23]. Clothing modifications were most common among individuals with head and neck, trunk, or leg involvement, consistent with previous studies identifying concealment strategies as coping mechanisms [3]. Collectively, these findings support the need for clinicians to address behavioural adaptations as part of holistic vitiligo management, including education on camouflage techniques and psychosocial support. Limitations This study has several limitations relating to representativeness. Recruitment through Facebook vitiligo support groups produced a convenience sample of social media users who had sufficient English literacy, internet access, and motivation to participate in an online questionnaire. As such, individuals who are older, digitally excluded, less engaged with online health communities, or less affected by their vitiligo may have been under‐represented. Conversely, people experiencing greater psychosocial burden, more visible disease, treatment dissatisfaction, or a stronger desire for support may have been more likely to participate, potentially inflating estimates of psychosocial impact. The sample was also disproportionately female and geographically concentrated in the United Kingdom and Australia, further limiting generalisability. While this approach broadened recruitment beyond tertiary clinics, it may not reflect the full spectrum of people living with vitiligo, particularly those managed solely in primary care, those not seeking support, or those from lower‐resource settings. Accordingly, the findings are best interpreted as describing the experiences of a community‐engaged online vitiligo cohort rather than the general vitiligo population. External validity is limited by the modest sample size and the geographical concentration, which may restrict applicability to other geographic and cultural contexts. The absence of a control group precluded adjustment for potential confounders, including disease severity, co‐existent conditions, psychological factors, socioeconomic status and cultural influences. Selection bias and measurement error are inherent to self‐reported, online survey methodologies, and individuals without internet or social media access may be under‐represented. Although prior studies suggest Facebook‐recruited samples can demonstrate demographic and psychometric characteristics comparable to traditional sampling methods [22], this may not hold true for smaller or condition‐specific cohorts. Fitzpatrick skin type was self‐reported, which may have been misclassified. Additionally, a technical error resulted in incomplete data for one VitiQoL item, precluding calculation of total VitiQoL scores and direct comparison with original validation studies. Nevertheless, analysis of individual items, interpreted alongside qualitative findings, provides valuable insight into patient‐reported experiences. Despite these limitations, social media‐based recruitment enabled inclusion of individuals who may not present to specialist clinics and allowed capture of patient‐prioritised concerns, including treatment pessimism, stigma, and barriers to care that may be less visible in clinic‐based cohorts. Conclusion Vitiligo imposes a substantial psychosocial burden, with this community‐recruited study offering insights into stigma, participation limitations, behavioural adaptations and barriers to care among affected individuals. Online recruitment enables inclusion of patients not engaged with specialist services, offering broader insights into real‐world experiences. Head and neck involvement was particularly burdensome, and male participants reported a greater emotional and social impact than previously described, while marital status appeared protective across several domains. For clinical practice, four priorities emerged: pursuing therapies, preventing disease progression, providing psychological support, and enhancing public awareness. Advances in biologic therapies for other skin conditions including eczema and psoriasis [24] suggest the potential for parallel therapeutic development in vitiligo. Accordingly, it is important that both primary referrers and patients remain informed about established and emerging vitiligo treatments available within specialist dermatology care. In the interim, patient care may be improved through promotion of sun‐safe practices, guidance on camouflage and skin care, and routine screening for psychological distress. Public awareness initiatives are essential to address persistent stigma and misconceptions, while enhanced clinician education and referral pathways may reduce perceived treatment limitations. Overall, these findings demonstrate that vitiligo burden extends beyond visible skin changes to include behavioural adaptations, treatment pessimism, and under‐recognised involvement of sensitive sites. These domains highlight the need for comprehensive, patient‐centred management strategies that integrate medical, psychological, and social support. Future research should aim to refine assessment tools and improve representation across diverse populations. Author Contributions M.N. and M.G. contributed to study conception and design. Data collection and analysis were performed by M.N. and M.G. All authors contributed to interpretation of the data, manuscript drafting, and critical revision, and approved the final version for submission. Funding The authors did not receive any specific funding for this study. Ethics Statement Ethics approval for this study was granted by the Human Research Ethics Committee of the University of Wollongong (Ethics number 2023/353). Consent All participants provided informed consent prior to participation. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Appendix S1: VitiQoL Questionnaire. Acknowledgements This study was conducted by the first author during medical training at the University of Wollongong. Open access publishing facilitated by University of Wollongong, as part of the Wiley ‐ University of Wollongong agreement via the Council of Australasian University Librarians. Data Availability Statement Research data are not shared. References Associated Data Supplementary Materials Appendix S1: VitiQoL Questionnaire. Data Availability Statement Research data are not shared.